Investigation of Vitamins, Glutathione and Stress Biomarkers in Blood Serum of Patients with Breast Cancer

dc.contributor.authorAwla Ibraim, Awat Hamad
dc.contributor.authorÖzer, Dursun
dc.contributor.authorKaratas, Fikret
dc.contributor.authorSaydam, Sinan
dc.date.accessioned2026-08-12T16:07:30Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstractBreast cancer is a genetic disease caused by the accumulation of mutations in neoplastic cells and is responsible for the highest morbidity and mortality. In this study, blood serum samples from 45 breast cancer patients and 32 healthy individuals (control group) were used. The amounts of vitamins (A, E, ?-carotene, C, B1, B2, B3, B5, B6, B9 and B12), glutathione (GSH, GSSG) stress biomarkers (4-HNE, MDA) were determined by HPLC. A significant difference was found between the breast cancer patients and the control group in terms of age and body mass index (BMI) (p<0.05). In the breast cancer group, fat-soluble vitamins, A, E and ?-carotene decreasing highly significant (p<0.001), decreasing water-soluble vitamins was found to be significant (p<0.05). No statistically significant difference was observed between the groups that received and did not receive treatment except vitamin B2 (p> 0.05) with in the cancer patients. Likewise, no significant difference was observed between the serum vitamin levels of breast cancer patients who breastfeed and not breastfeed, except for vitamins B2 and B3 (p>0.05). A high level of significant difference was observed between GSH, GSSG, MDA and 4-HNE in the breast cancer patient and control groups (p<0.001). There was no significant difference found in GSSG, MDA and HNE values according to the treatment status of breast cancer patients, on the other hand, a significant difference was observed in GSH and GSH/GSSG values (p<0.05). While there was no significant difference in GSH, GSSG, MDA and 4-HNE values according to the breastfeeding status of patients, a significant difference was observed in GSH/GSSG values (p<0.05). © 2023, Sakarya University. All rights reserved.
dc.description.sponsorshipFirat University Scientific Research Center; Firat University Scientific Research Projects Management Unit, FUBAP, (FUBAP FF.19.33)
dc.identifier.doi10.16984/saufenbilder.1080420
dc.identifier.endpage296
dc.identifier.issn1301-4048
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85218145134
dc.identifier.scopusqualityQ3
dc.identifier.startpage285
dc.identifier.trdizinid1166645
dc.identifier.urihttps://doi.org/10.16984/saufenbilder.1080420
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1166645
dc.identifier.urihttps://hdl.handle.net/11508/40756
dc.identifier.volume27
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherSakarya University
dc.relation.ispartofSakarya University Journal of Science
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20260511
dc.subject4-hydroxy neoneal; Breast cancer; Malondialdehyde; Oxidised glutathione; Reduced glutathione; Vitamins
dc.titleInvestigation of Vitamins, Glutathione and Stress Biomarkers in Blood Serum of Patients with Breast Cancer
dc.typeArticle

Dosyalar